CapTemY90
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CapTemY90, covering 2025-12-10 to 2025-12-10. Get the full timeline:
Most recent: Clinical Trial Update: CapTemY90 for Grade 2/3 NET Liver Metastases [Phase 2]